Crispr Therapeutics shares owned by Manhattan West Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Manhattan West Asset Management
from 13F filings
Historical chart of Manhattan West Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Manhattan West Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Manhattan West Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $463k | 7.1k | 64.81 |
| 2025-06-30 | $333k | 6.8k | 48.64 |
| 2023-12-31 | $216k | 3.4k | 62.60 |
More positions owned by Manhattan West Asset Management
View all positions for Manhattan West Asset Management